EducationalReading Your CBD Lab Report in 2026: Beyond Potency
A Certificate of Analysis (COA) is the single most important document a hemp buyer can read, and the headline cannabinoid percentage is only the first line of it. A complete report also verifies that the product carries less than 0.3% delta-9 THC by dry weight—the legal ceiling set for hemp under the 2018 Farm Bill—and confirms whether the extract is an isolate, broad-spectrum, or full-spectrum oil. Because the FDA has not established a formal manufacturing standard for over-the-counter CBD, third-party lab testing is currently the main way consumers can independently confirm what is actually in a bottle.
Beyond potency, a rigorous COA screens for the contaminants that can concentrate during extraction: residual solvents, pesticides, and heavy metals such as lead, arsenic, cadmium, and mercury, which hemp is known to draw up from soil. It should also report microbial and mycotoxin results and, on full- and broad-spectrum products, a terpene profile. Look for a recent test date, a batch number that matches the bottle, and an accredited (ISO 17025) laboratory named on the document rather than an anonymous in-house result.
None of this makes CBD a treatment for any medical condition. Apart from Epidiolex, a prescription drug approved for certain rare seizure disorders, the FDA has not approved CBD to diagnose, treat, cure, or prevent disease, and has not cleared it as a dietary supplement or food additive. A clean COA tells you a product is what it claims to be; it is not medical advice, and anyone considering CBD—especially alongside other medications—should speak with a healthcare provider first.
Sources: U.S. Food & Drug Administration; Agriculture Improvement Act of 2018; NIH NCCIH
May 20, 202611 min read
